Skip to main content
MET
NYSE Finance

MetLife 10-Q: Q3 Net Income $2.4B, Adjusted EPS $2.85, $86M Assumption-Review Hit

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Insurance Stocks · Financial
Sentiment info
Neutral
Importance info
7
Price
$100
Mkt Cap
$63.389B
52W Low
$67.33
52W High
$106.719
52W Position info
49% above low
Off High info
6.3% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

MET sits 49% above its 52-week low of $67.33.

Summary

MetLife's Q3 10-Q confirms the already-reported $2.4 billion quarterly net income and $2.85 adjusted EPS, while disclosing an $86 million after-tax actuarial assumption-review loss and a $7.2 billion year-to-date drop in accumulated other comprehensive income to $(25.3) billion.


Key Events · Earnings and Guidance · MET

  • Q3 Earnings Confirmed in Full 10-Q

    Net income available to common shareholders was $2,351 million for Q3 2026 versus $818 million a year earlier; nine-month net income was $4,196 million versus $2,395 million.

  • Assumption Review Swings to a Loss

    The actuarial assumption review produced an $86 million after-tax loss versus a $102 million gain in Q3 2025, a $188 million swing, driven by long-term care lapse and premium-rate assumption updates and less favorable mortality in pension risk transfer.

  • Book Value Hit by Bond Marks

    Accumulated other comprehensive income fell to $(25,304) million from $(18,084) million at December 31, 2025, as gross unrealized losses on available-for-sale securities rose $15.8 billion to $43.9 billion on higher interest rates.

  • Buyback and Debt Actions

    MetLife repurchased 25,627,945 shares for $2.1 billion in the first nine months, leaving $2,972 million on the August 5, 2026 $3.0 billion authorization; it also issued $1.0 billion of 5.850% subordinated debentures due 2056 in February 2026.


Analysis · MET · Finance

The headline numbers were already out on November 4, but the full 10-Q is where the balance-sheet story lives. Book value took a hit: accumulated other comprehensive income fell to $(25.3) billion from $(18.1) billion at year-end as gross unrealized losses on the bond portfolio widened by $15.8 billion to $43.9 billion on higher rates. That is an accounting mark, not a credit event — the company says it does not intend to sell and expects to recover amortized cost — but it does erode reported equity and the capital cushion regulators and rating agencies watch. Against that, the actuarial assumption review swung to an $86 million after-tax loss from a $102 million gain a year ago, mostly long-term care lapse and premium-rate assumptions plus weaker mortality in pension risk transfer. Capital return continues: 25.6 million shares repurchased for $2.1 billion in the first nine months, with $2.97 billion left on the August authorization.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MET was trading at $100.00 on NYSE in the Finance sector, with a market capitalization of approximately $63.4B. The 52-week trading range was $67.33 to $106.72. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MET - Latest Insights

MET
Nov 07, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $98.27
Real-time Price: $96.29 info
Change: -$1.98 (-2%) info
Market Cap: $60.158B info
MET
Nov 04, 2026, 4:32 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $104.92
Real-time Price: $96.29 info
Change: -$8.63 (-8%) info
Market Cap: $60.158B info
MET
Nov 04, 2026, 4:22 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $104.92
Real-time Price: $96.29 info
Change: -$8.63 (-8%) info
Market Cap: $60.158B info
MET
Nov 04, 2026, 4:15 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $102.89
Real-time Price: $96.29 info
Change: -$6.60 (-6%) info
Market Cap: $60.158B info
MET
Sep 24, 2026, 4:13 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $97.25
Real-time Price: $96.29 info
Change: -$0.960 (-0.99%) info
Market Cap: $60.158B info